In-Sian Pouw
Pediatric Endocrinology · Lacombe, LANPI 1194741355
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations.
Across 103 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lifescan, Inc.$256
- Dexcom, Inc.$239
- Insulet Corporation$162
- Sanofi-aventis U.S. LLC$147
- AbbVie$137
- Sanofi Pasteur Inc.$86
- plus $974 from 26 others
What the payments were for
- Consulting fees$251%
- Food & beverage$1,95298%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lifescan, Inc. | 15 | $256 |
| Dexcom, Inc. | 6 | $239 |
| Insulet Corporation | 9 | $162 |
| Sanofi-aventis U.S. LLC | 7 | $147 |
| AbbVie | 8 | $137 |
| Sanofi Pasteur Inc. | 4 | $86 |
| Pfizer | 4 | $85 |
| Neurocrine Biosciences, Inc. | 3 | $68 |
| Medtronic(2 entities) | 4 | $64 |
| Novo Nordisk | 3 | $61 |
| Zealand Pharma US, Inc. | 3 | $59 |
| Lilly USA, LLC | 3 | $56 |
| Shire North American Group Inc | 3 | $55 |
| Ascendis Pharma Endocrinology Inc | 3 | $53 |
| Abbott | 3 | $47 |
| AstraZeneca | 3 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Biomarin Pharmaceutical Inc. | 2 | $39 |
| Tolmar Pharmaceuticals, Inc. | 2 | $38 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| Sequel Med Tech, LLC | 2 | $32 |
| Endo Pharmaceuticals Inc. | 2 | $26 |
| Tandem Diabetes Care, Inc. | 1 | $20 |
| BD | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Cipher Pharmaceuticals US LLC | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Eton Pharmaceuticals, Inc. | 1 | $13 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM CGM$136
How this compares
Too few pediatric endocrinology providers in Louisianato place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Lacombe
- Stuart ChalewNew Orleans$7K
- Ricardo GomezNew Orleans$6K
- Janna Flint WilsonLafayette$5K
- Cielo AlleynNew Orleans$3K
- Dania Felipe-RamirezNew Orleans$3K
- Sasi PenukondaShreveport$2K
- Arlette Soros DupreNew Orleans$2K
- Chantal LutfallahBaton Rouge$2K
- James GardnerBaton Rouge$2K
- Snigdha LikkiShreveport$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.